Dr. Armstrong currently serves as Professor of Surgery (with Tenure) at the University of Arizona. He holds a Masters of Science degree in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He also is co-founder of the Southern Arizona Limb Salvage Alliance (SALSA).
Dr. Armstrong has produced more than 290 peer-reviewed research papers in more than two dozen medical journals as well as over two dozen book chapters. He is presently co-Editor of the American Diabetes Association’s (ADA) Clinical Care of the Diabetic Foot. Dr. Armstrong is past Chair of Scientific Sessions for the ADA’s Foot Care Council, a past member of the National Board of Directors of the ADA and a former commissioner with the Illinois State Diabetes commission. He presently serves on the Infectious Disease Society of America’s Diabetic Foot Infection Advisory Committee. He is also founder and co-chair of the annual International Diabetic Foot Conference (DF-con).
Dr. Joseph currently serves as Podiatric and Infectious Diseases Attending at Roxborough Memorial Hospital in Philadelphia and in the section of podiatric medicine at the Coatesville VA Medical Center. He is a nationally recognized specialist in the treatment of lower extremity infectious diseases.
Dr. Joseph is presently Editor-in-Chief of the Journal of the American Podiatric Medical Association, Editorial Advisor to the Foot and Ankle Quarterly and member of the editorial boards of Podiatric Management and Podiatry Today. He is the author of numerous publications, books and book chapters, presentations and the author of the Handbook of Lower Extremity Infections.
Dr. Joseph received his Doctor of Podiatric Medicine degree (magna cum laude) from the William M. Scholl College of Podiatric Medicine and performed his Residency in Podiatric Medicine/Surgery at St. Joseph's Hospital. Dr. Joseph is Board Certified in Primary Podiatric Medicine and the American Board of Podiatric Orthopedics & Primary Podiatric Medicine. He is a Fellow in the Infectious Disease Society of America and sits on the IDSA Diabetic Foot Infection Guidelines Committee. He is also Board Certified in the American College of Foot & Ankle Orthopedics and Medicine and a Fellow in the College of Physicians of Philadelphia.
Dr. Lipsky is Emeritus Professor of Medicine, University of Washington; Visiting Professor, Infectious Diseases, University of Geneva and Teaching Associate, Green Templeton College, University of Oxford. Previously, he was Director of the Primary Care Clinic, and the Antibiotic Research Clinic, VA Puget Sound HCS, Seattle. He is a leading expert on the problem of foot infections that occur as a complication of diabetes. He is a Fellow of the American College of Physicians, Infectious Diseases Society of America, and the Royal College of Physicians. Dr. Lipsky has published over 250 peer-reviewed scientific publications, reviews and book chapters on various infectious diseases topics; presented over 150 abstracts at scientific conferences all over the world; and authored two textbooks on antibiotic therapy and one on diabetic foot infections.
Dr. Lipsky has served as a consultant to dozens of pharmaceutical and biotechnology companies. He also is Chair of the diabetic foot infection guidelines committees of both the Infectious Diseases Society of America, and the International Working Group on the Diabetic Foot (IWGDF), and is a member of the IWGDF Osteomyelitis Committee. Dr. Lipsky received his medical training at Cornell University Medical College and the University of Washington.
Dr. Wilkin is a Founding Director (Retired) of the Division of Dermatology and Dental Products, US Food and Drug Administration. Currently, Dr. Wilkin consults with pharmaceutical companies on regulatory matters and is a member of the FDA’s Dermatology Drugs Advisory Committee. Prior to joining the FDA, Dr. Wilkin was Director of Dermatology at the Ohio State University and Professor of Pharmacology and Medicine. He is the author of more than 130 publications in dermatology and clinical pharmacology.
Dr. Wilkin received his BA and MS in zoology from Ohio State University, and a medical degree from the Ohio State University College of Medicine. Dr. Wilkin presently serves as chairman of the medical advisory board for the National Rosacea Society as well as having chaired their Expert Committees on the Classification and Staging System for Rosacea. He also has served on the American Academy of Dermatology’s (AAD) Ad Hoc Task Force on the Academy’s Efforts with FDA and on their Environment and Drugs Committee. Dr. Wilkin is active in the American Society for Clinical Pharmacology and Therapeutics, having chaired the Dermatologic and Allergic Diseases Section and the Constitution and By-laws Committee for several years, as well as serving in other capacities.
He is a fellow of both the AAD and the American College of Physicians, a member of the American Dermatological Association and board certified by both the American Board of Dermatology and the American Board of Clinical Pharmacology.
Dr. Zasloff currently serves as Professor in the Departments of Surgery & Pediatrics, and Director, Surgical Immunology, at Georgetown University School of Medicine and Dentistry. He also discovered pexiganan and has been involved in early stage development of other peptides.
Dr. Zasloff earned his M.D., Ph.D. at New York University School of Medicine in the Medical Scientist Training Program, sponsored by the National Institutes of Health. Dr. Zasloff joined the National Institutes of Health for postdoctoral studies in molecular genetics, and was later named Chief of the Human Genetics Branch of the National Institutes of Child Health and Human Development. Subsequently, he became the Charles E. H. Upham Professor of Pediatrics and Genetics at the University of Pennsylvania School of Medicine and Chief of the Division of Human Genetics of the Children’s Hospital of Philadelphia.